NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Coty Inc. (NYSE: COTY) for potential violations of the federal securities laws. If you invested in Coty, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/coty-inc-class-action. Why Is Coty being Investigated?Coty is one of the world’s largest beauty companies with a portfolio of brands across fragrance, color cosmetics, and skin and b ...

NEW YORK, Nov. 02, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Savara Inc. (NASDAQ: SVRA) between March 7, 2024 and May 23, 2025, both dates inclusive (the “Class Period”), of the important November 7, 2025 lead plaintiff deadline. SO WHAT: If you purchased Savara securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO N ...

NEW YORK, Nov. 02, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Lantheus Holdings, Inc. (NASDAQ: LNTH) between February 26, 2025 and August 5, 2025, both dates inclusive (the “Class Period”), of the important November 10, 2025 lead plaintiff deadline. SO WHAT: If you purchased Lantheus securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arra ...

诉讼案件基本信息 - 罗森律师事务所提醒在2024年11月8日至2025年8月6日期间购买Fortinet公司普通股的投资者注意2025年11月21日的首席原告截止日期 [1] - 针对Fortinet的集体诉讼已经提起，投资者可通过指定网址或电话联系以加入该诉讼 [2][6] 诉讼指控内容 - 指控方称，被告就FortiGate设备升级周期的影响和可持续性做出了重大虚假和误导性陈述 [4] - 被告曾表示该“更新周期”是“有史以来最大的一次”，预计将在2025年和2026年产生约4亿至4.5亿美元的产品收入，并将在2025年下半年及以后“获得动力” [4] - 诉讼指控这些陈述存在重大虚假和误导性，实际上该更新周期由老旧产品构成，仅占公司业务的“一小部分”，且其带来的收益从未像陈述的那样可观 [5] - 被告被指控隐瞒了其并不清楚可升级的FortiGate防火墙真实数量的事实，并在告知投资者更新周期将在两年内获得动力的同时，在2025年第二季度末前的几个月内激进地完成了约一半的更新 [5] - 当真实情况进入市场时，投资者遭受了损失 [5]

NEW YORK, Nov. 02, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of aTyr Pharma, Inc. (NASDAQ: ATYR) between January 16, 2025 and September 12, 2025, both dates inclusive (the “Class Period”), of the important December 8, 2025 lead plaintiff deadline. SO WHAT: If you purchased aTyr Pharma common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee a ...

诉讼事件概述 - 领先证券律师事务所Bleichmar Fonti & Auld LLP宣布，已对Molina Healthcare公司及其部分高级执行官提起集体诉讼，指控其可能违反联邦证券法 [1] - 投资者需在2025年12月2日前向法院申请担任本案首席原告，诉讼基于《1934年证券交易法》第10(b)和20(a)条提出，案件正在美国加州中区地方法院审理 [2] 诉讼指控核心 - 公司在相关期间向投资者声称其"盈利增长前景""进入2025年表现稳健"，并"持续监控使用模式"以"减轻医疗成本通胀的负面影响" [3] - 指控称，事实上公司面临所有三条业务线使用率上升带来的医疗成本压力，且无法缓解这些压力 [3] 业绩披露与市场反应 - 2025年7月7日，公司披露2025年第二季度调整后每股收益约为5.50美元，低于先前预期，并将全年调整后每股收益预期中点下调10.2%至21.50美元至22.50美元的区间 [4] - 2025年7月23日，公司进一步将2025年全年调整后每股收益预期下调至不低于19.00美元，原因包括行为健康、药房及住院和门诊服务的使用率增加 [4] - 受此消息影响，公司股价从2025年7月23日的每股190.25美元下跌32.03美元（跌幅16.8%），至2025年7月24日的每股158.22美元 [4] 公司业务背景 - Molina Healthcare是一家健康保险公司，通过Medicaid和Medicare项目为低收入个人提供管理式医疗服务 [3]

诉讼案件基本信息 - 集体诉讼针对Marex Group plc (NASDAQ: MRX) 在2024年5月16日至2025年8月5日期间购入其证券的购买者 [1] - 首席原告申请的截止日期为2025年12月8日 [1][2] 诉讼指控细节 - 指控称被告在集体诉讼期间做出了重大虚假和/或误导性陈述和/或未能披露相关信息 [4] - 具体指控包括Marex向自身出售场外金融工具 [4] - 指控指出Marex在其子公司与关联公司之间的财务报表存在不一致，涉及公司间应收款和贷款 [4] - 由于上述问题，Marex的财务报表无法被信赖 [4] - 指控认为被告关于公司业务、运营和前景的正面陈述因此存在重大误导性和/或缺乏合理依据 [4] 律所背景信息 - Rosen Law Firm专注于证券集体诉讼和股东派生诉讼 [3] - 该律所曾达成针对中国公司的史上最大证券集体诉讼和解 [3] - ISS Securities Class Action Services数据显示，该律所在2017年达成的证券集体诉讼和解数量排名第一 [3] - 自2013年以来，该律所每年排名均在前四，并为投资者追回数亿美元，其中2019年即为投资者获得超过4.38亿美元 [3]

NEW YORK, Nov. 01, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Molina Healthcare, Inc. (NYSE: MOH) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Molina, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/molina-healthcare-inc-class-action. Investors have until December 2, 2025, to ask the Court to be appoin ...

NEW YORK, Oct. 31, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Fly-E Group, Inc. (NASDAQ: FLYE) between July 15, 2025 and August 14, 2025, both dates inclusive (the “Class Period”), of the important November 10, 2025 lead plaintiff deadline. SO WHAT: If you purchased Fly-E securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHA ...

NEW YORK, Oct. 31, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds sellers of ordinary shares, including those that sold into the Merger of Sina Corporation (NASDAQ: SINA) between October 13, 2020 and March 22, 2021, both dates inclusive (the “Class Period”), of the important November 18, 2025 lead plaintiff deadline in the securities class action. SO WHAT: If you sold Sina ordinary shares, including those that sold into the Merger, during the Class Period you may b ...